Source:http://linkedlifedata.com/resource/pubmed/id/11747107
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2001-12-17
|
pubmed:abstractText |
A fast, sensitive and specific method is presented for the quantification of RSD921 in human plasma by liquid chromatography coupled with tandem mass spectrometry using tri-deuterated RSD921 (3d-RSD921) as an internal standard. A single-step liquid/liquid extraction was performed with diethyl ether/hexane (80 : 20, v/v) using 0.5 ml of plasma. The plasma calibration curves were linear from 0.1 to 20 ng ml(-1) (r > 0.999). Between-run precision, based on the percent relative deviation for replicate (n = 40) quality controls, was < or =7.27% (0.5 ng ml(-1)), < or =7.39% (5.0 ng ml(-1)), and < or =5.06% (20.0 ng ml(-1)). Between-run accuracies, based on the relative error, were +/-2.59%, +/-1.23% and +/-1.64% respectively. The method was developed to evaluate the pharmacokinetic profile after 15 min of intravenous stepwise-ascending infusion dose of RSD921 in 18 healthy volunteers. A dissociation study of protonated RSD921 and 3d-RSD921 by collision-induced dissociation using in-source fragmentation and tandem mass spectrometry is also presented.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anesthetics, Local,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Deuterium,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/PD 117302,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles,
http://linkedlifedata.com/resource/pubmed/chemical/Thiophenes
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1076-5174
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1133-9
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11747107-Anesthetics, Local,
pubmed-meshheading:11747107-Anti-Arrhythmia Agents,
pubmed-meshheading:11747107-Calibration,
pubmed-meshheading:11747107-Chromatography, High Pressure Liquid,
pubmed-meshheading:11747107-Clinical Trials, Phase I as Topic,
pubmed-meshheading:11747107-Deuterium,
pubmed-meshheading:11747107-Humans,
pubmed-meshheading:11747107-Indicators and Reagents,
pubmed-meshheading:11747107-Mass Spectrometry,
pubmed-meshheading:11747107-Pyrroles,
pubmed-meshheading:11747107-Quality Control,
pubmed-meshheading:11747107-Reference Standards,
pubmed-meshheading:11747107-Thiophenes
|
pubmed:year |
2001
|
pubmed:articleTitle |
Determination of RSD921 in human plasma by high-performance liquid chromatography-tandem mass spectrometry using tri-deuterated RSD921 as internal standard: application to a phase I clinical trial.
|
pubmed:affiliation |
Cartesius Analytical Unit, Department of Pharmacology ICB-USP, 05508-900, São Paulo, SP, Brazil.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|